Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia

Background: Mild cognitive impairment and cognitive impairment, no dementia, are emerging terms that encompass the clinical state between normal cognition and dementia in elderly people. Controversy surrounds their characterization, definition and application in clinical practice. In this article, we provide physicians with practical guidance on the definition, diagnosis and treatment of mild cognitive impairment and cognitive impairment, no dementia, based on recommendations from the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, held in March 2006. Methods: We developed evidence-based guidelines using systematic literature searches, with specific criteria for study selection and quality assessment, and a clear and transparent decision-making process. We selected studies published from January 1996 to December 2005 that had mild cognitive impairment or cognitive impairment, no dementia, as the outcome. Subsequent to the conference, we searched for additional articles published between January 2006 and January 2008. We graded the strength of evidence using the criteria of the Canadian Task Force on Preventive Health Care. Results: We identified 2483 articles, of which 314 were considered to be relevant and of good or fair quality. From a synthesis of the evidence in these studies, we made 16 recommendations. In brief, family physicians should be aware that most types of dementia are preceded by a recognizable phase of mild cognitive decline. They should be familiar with the concepts of mild cognitive impairment and of cognitive impairment, no dementia. Patients with these conditions should be closely monitored because of their increased risk for dementia. Leisure activities, cognitive stimulation and physical activity could be promoted as part of a healthy lifestyle in elderly people and those with mild cognitive impairment. Vascular risk factors should be treated optimally. No other specific therapies can yet be recommended. Interpretation: Physicians will increasingly see elderly patients with mild memory loss, and learning an approach to diagnosing states such as mild cognitive impairment is now warranted. Close monitoring for progression to dementia, promotion of a healthy lifestyle and treatment of vascular risk factors are recommended for the management of patients with mild cognitive impairment.

[1]  Janice E Graham,et al.  Prevalence and severity of cognitive impairment with and without dementia in an elderly population , 1997, The Lancet.

[2]  D. Zaitchik,et al.  Predicting conversion to Alzheimer disease using standardized clinical information. , 2000, Archives of neurology.

[3]  G. Adler,et al.  Mild Cognitive Impairment in Old-Age Depression Is Associated with Increased EEG Slow-Wave Power , 1999, Neuropsychobiology.

[4]  Hiroko H Dodge,et al.  Exercise Level and Cognitive Decline: The MoVIES Project , 2004, Alzheimer disease and associated disorders.

[5]  H. Tuokko,et al.  Five-year follow-up of cognitive impairment with no dementia. , 2003, Archives of neurology.

[6]  L. Candelise,et al.  Galantamine for Alzheimer’s Disease and Mild Cognitive Impairment , 2007, Neuroepidemiology.

[7]  Yvette I. Sheline,et al.  Potential antecedent marker of Alzheimer disease , 2006 .

[8]  P. Knipschild,et al.  Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. , 2003, Journal of clinical epidemiology.

[9]  K. Ottenbacher,et al.  The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. , 2004, Archives of physical medicine and rehabilitation.

[10]  H. Wiśniewski,et al.  Alzheimer's disease and related disorders. , 1986, British medical bulletin.

[11]  H. Buschke,et al.  The effects of preclinical dementia on estimates of normal cognitive functioning in aging. , 1996, The journals of gerontology. Series B, Psychological sciences and social sciences.

[12]  K. Blennow,et al.  Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment , 1999, Neuroscience Letters.

[13]  J. Schneider,et al.  Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions , 2005, Neurology.

[14]  C. Good,et al.  Diet and serum potassium in patients on ACE inhibitors. , 1995, JAMA.

[15]  I. Deary,et al.  The Effects of Antihypertensive Treatment on Cognitive Function: Results from the HOPE Study , 1996, Journal of the American Geriatrics Society.

[16]  Sylvie Belleville,et al.  Improvement of Episodic Memory in Persons with Mild Cognitive Impairment and Healthy Older Adults: Evidence from a Cognitive Intervention Program , 2006, Dementia and Geriatric Cognitive Disorders.

[17]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[18]  B L Holman,et al.  Preclinical prediction of Alzheimer's disease using SPECT , 1998, Neurology.

[19]  Y. Joanette,et al.  Mild cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis , 2007, Alzheimer's & Dementia.

[20]  G. Schellenberg,et al.  Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E 4 status , 1999 .

[21]  R. Collins,et al.  Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions , 2004, The Lancet.

[22]  B. Winblad,et al.  Influence of social network on occurrence of dementia: a community-based longitudinal study , 2000, The Lancet.

[23]  Robert D. Harris,et al.  Vascular , 1993 .

[24]  E. Tangalos,et al.  CME Practice parameter: , 2022 .

[25]  E B Larson,et al.  Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. , 1999, Neurology.

[26]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[27]  Ayanna K. Thomas,et al.  Theoretical Perspectives on Cognitive Aging , 2019, Handbook of Medical Neuropsychology.

[28]  E G Tangalos,et al.  Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.

[29]  J. Jolles,et al.  Distinction Between Preclinical Alzheimer's Disease and Depression , 2000, Journal of the American Geriatrics Society.

[30]  A. Ott Risk of dementia: The Rotterdam Study , 1997 .

[31]  G. Alexopoulos Heterogeneity and comorbidity in dementia‐depression syndromes , 1991 .

[32]  A. Drzezga,et al.  Primary Degenerative Mild Cognitive Impairment: Study Population, Clinical, Brain Imaging and Biochemical Findings , 2001, Dementia and Geriatric Cognitive Disorders.

[33]  Timothy Kwok,et al.  Cognitive intervention for community‐dwelling older persons with memory problems: telemedicine versus face‐to‐face treatment , 2005, International journal of geriatric psychiatry.

[34]  P. Macfarlane,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.

[35]  L. Goossens,et al.  Improving memory performance in the aged through mnemonic training: a meta-analytic study. , 1992, Psychology and aging.

[36]  W. Greenough,et al.  Environmental influences on cognitive and brain plasticity during aging. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[37]  J. Schneider,et al.  Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.

[38]  W. Snow,et al.  The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits. , 1996, Archives of neurology.

[39]  George W Rebok,et al.  Effects of cognitive training interventions with older adults: a randomized controlled trial. , 2002, JAMA.

[40]  M. Bobinski,et al.  Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Schneider,et al.  Individual differences in rates of change in cognitive abilities of older persons. , 2002, Psychology and aging.

[42]  H. Chertkow,et al.  Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD , 2000, Neurology.

[43]  H. Tuokko,et al.  Cognitive Impairment with No Dementia (CIND): Longitudinal Studies, the Findings, and the Issues , 2000, The Clinical neuropsychologist.

[44]  B. Boeve,et al.  Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy , 2001, Movement disorders : official journal of the Movement Disorder Society.

[45]  A. Smith,et al.  Use of structural imaging to study the progression of Alzheimer's disease. , 1996, British medical bulletin.

[46]  D. Schaid,et al.  Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.

[47]  Alessandro Padovani,et al.  The Predementia Diagnosis of Alzheimer Disease , 2004, Alzheimer disease and associated disorders.

[48]  E. Barrett-Connor,et al.  Diabetes, impaired fasting glucose, and development of cognitive impairment in older women , 2004, Neurology.

[49]  K. Meguro,et al.  Therapeutic Psychosocial Intervention for Elderly Subjects With Very Mild Alzheimer Disease in a Community: The Tajiri Project , 2002, Alzheimer disease and associated disorders.

[50]  C. Junqué,et al.  Neuropsychological and Genetic Differences Between Age‐Associated Memory Impairment and Mild Cognitive Impairment Entities , 2001, Journal of the American Geriatrics Society.

[51]  R. Petersen,et al.  Mild cognitive impairment: transition between aging and Alzheimer's disease. , 2000, Neurologia.

[52]  C. Kawas,et al.  Plasma total cholesterol, LDL, HDL levels and the risk of Alzheimer disease The Baltimore Longitudinal Study of Aging , 2002 .

[53]  C. Jonker,et al.  Are memory complaints predictive for dementia? A review of clinical and population‐based studies , 2000, International journal of geriatric psychiatry.

[54]  H. Kavirajan,et al.  Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease , 2005, Neurology.

[55]  D. A. Bennett,et al.  Natural history of mild cognitive impairment in older persons , 2002, Neurology.

[56]  Howard Chertkow,et al.  Olfaction in patients with mild cognitive impairment and Alzheimer's disease , 2008, Neurobiology of Aging.

[57]  J. Schneider,et al.  Participation in cognitively stimulating activities and risk of incident Alzheimer disease. , 2002, JAMA.

[58]  T. Fritsch,et al.  The relationships between television viewing in midlife and the development of Alzheimer’s disease in a case-control study , 2005, Brain and Cognition.

[59]  Nick C Fox,et al.  Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study , 2007, The Lancet Neurology.

[60]  Robert B Wallace,et al.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.

[61]  The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group. , 2000, Neurology.

[62]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[63]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[64]  R. D'Agostino,et al.  Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study , 2003, International Journal of Obesity.

[65]  Andrew Kertesz,et al.  Diagnosis and treatment of dementia: 2. Diagnosis , 2008, Canadian Medical Association Journal.

[66]  J. Touchon,et al.  A Typology of Sub-Clinical Senescent Cognitive Disorder , 1996, British Journal of Psychiatry.

[67]  Kenneth Rockwood,et al.  Variations in case definition affect prevalence but not outcomes of mild cognitive impairment , 2003, Neurology.

[68]  L. Thal,et al.  A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment , 2005, Neuropsychopharmacology.

[69]  V. Hachinski Preventable senility: a call for action against the vascular dementias , 1992, The Lancet.

[70]  Neil Chapman,et al.  Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. , 2003, Archives of internal medicine.

[71]  J. Touchon,et al.  Disability and mild cognitive impairment: a longitudinal population‐based study , 2001, International journal of geriatric psychiatry.

[72]  S. Salloway,et al.  Efficacy of donepezil in mild cognitive impairment , 2004, Neurology.

[73]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[74]  M. Samuel,et al.  Efficacy and Safety of OK-432 Sclerotherapy for Giant Cystic Hygroma in a Newborn , 2000, Fetal Diagnosis and Therapy.

[75]  D. Hogan,et al.  Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. , 1995, Archives of neurology.

[76]  M. Freedman,et al.  Mild cognitive impairment and cognitive impairment, no dementia: Part B, therapy , 2007, Alzheimer's & Dementia.

[77]  G. Kemmler,et al.  Long-term improvements in cognitive performance through computer-assisted cognitive training: A pilot study in a residential home for older people , 2003, Aging & mental health.

[78]  H. Chertkow Diagnosis and treatment of dementia: Introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia , 2007, Canadian Medical Association Journal.

[79]  S. Gauthier,et al.  Mild cognitive impairment is not a clinical entity and should not be treated. , 2005, Archives of neurology.

[80]  R. Petersen,et al.  Aging, mild cognitive impairment, and Alzheimer's disease. , 2000, Neurologic clinics.

[81]  C. Patterson,et al.  Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease , 2008, Canadian Medical Association Journal.

[82]  H Bergman,et al.  Lack of Prognostic Significance of SPECT Abnormalities in Non-demented Elderly Subjects with Memory Loss , 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[83]  C. Gottfries,et al.  Identification of Cognitive Impairment in the Elderly: Homocysteine Is an Early Marker , 1998, Dementia and Geriatric Cognitive Disorders.

[84]  R. Petersen,et al.  Mild cognitive impairment , 2006, The Lancet.

[85]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[86]  D. Blacker Mild cognitive impairment--no benefit from vitamin E, little from donepezil. , 2005, The New England journal of medicine.

[87]  Hilkka Soininen,et al.  Prevalence of mild cognitive impairment: A population-based study in elderly subjects , 2000, Neurobiology of Aging.

[88]  D. Riemann,et al.  Cholinergic neurotransmission, REM sleep and depression. , 1994, Journal of psychosomatic research.

[89]  D. Bliwise Is sleep apnea a cause of reversible dementia in old age? , 1996, Journal of the American Geriatrics Society.

[90]  P. Neu,et al.  Comorbidity of mild cognitive disorder and depression – a neuropsychological analysis , 2000, European Archives of Psychiatry and Clinical Neuroscience.

[91]  K. Marder,et al.  Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. , 2000, The American journal of psychiatry.

[92]  J. Kessler,et al.  DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia , 2004, International journal of geriatric psychiatry.

[93]  N. Fox Increased rates of atrophy in early and preclinical AD: Studies with registration of serial MRI , 2000, Neurobiology of Aging.

[94]  C. Jack,et al.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.

[95]  Agneta Nordberg,et al.  PET imaging of amyloid in Alzheimer's disease , 2004, The Lancet Neurology.

[96]  J. Jolles,et al.  Ten-year risk of dementia in subjects with mild cognitive impairment , 2006, Neurology.

[97]  T. Grabowski Preclinical Alzheimer Disease: Neuropsychological Test Performance 1.5 to 8 Years Prior to Onset , 2006 .

[98]  A P Marsh,et al.  Memory enhancement training for older adults with mild cognitive impairment: A preliminary study , 2002, Aging & mental health.

[99]  A. Newman,et al.  The metabolic syndrome, inflammation, and risk of cognitive decline. , 2004, JAMA.

[100]  J. Lindsay,et al.  Physical activity and risk of cognitive impairment and dementia in elderly persons. , 2001, Archives of neurology.

[101]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[102]  H. Feldman,et al.  The Consortium to Investigate Vascular Impairment of Cognition: Methods and First Findings , 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[103]  A. Mitchell,et al.  Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. , 2002, JAMA.

[104]  D. Bennett Mild cognitive impairment. , 2004, Clinics in geriatric medicine.

[105]  Yaakov Stern,et al.  Questionable Dementia: Clinical Course and Predictors of Outcome , 1997, Journal of the American Geriatrics Society.

[106]  A. Levy,et al.  A Canadian Cohort Study of Cognitive Impairment and Related Dementias (ACCORD): Study Methods and Baseline Results , 2003, Neuroepidemiology.

[107]  D. Bennett Update on mild cognitive impairment , 2003, Current neurology and neuroscience reports.

[108]  M. Albert,et al.  Preclinical prediction of AD using neuropsychological tests , 2001, Journal of the International Neuropsychological Society.

[109]  M. Albert,et al.  Amnestic MCI or prodromal Alzheimer's disease? , 2004, The Lancet Neurology.

[110]  V. Hachinski Vascular dementia: a radical redefinition. , 1994, Dementia.

[111]  D. Bennett,et al.  Vitamin E and donepezil for the treatment of mild cognitive impairment. , 2005, The New England journal of medicine.

[112]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[113]  G. Alexopoulos,et al.  The course of geriatric depression with "reversible dementia": a controlled study. , 1993, The American journal of psychiatry.

[114]  C. Jack,et al.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.

[115]  K. Ball,et al.  Long-term effects of cognitive training on everyday functional outcomes in older adults. , 2006, JAMA.